ICOS Gene Immunodeficiency common variable type 1 Genetic Test
Components: ICOS Gene Immunodeficiency common variable type 1 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for ICOS Gene Immunodeficiency common variable type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ICOS Gene Immunodeficiency common variable type 1 NGS Genetic DNA Test gene ICOS
Test Details:
ICOS gene immunodeficiency common variable type 1 NGS genetic test is a diagnostic test that uses next-generation sequencing (NGS) technology to analyze the genetic sequence of the ICOS gene. This test is specifically designed to identify mutations or variations in the ICOS gene that are associated with common variable immunodeficiency type 1 (CVID1). CVID1 is a primary immunodeficiency disorder characterized by a reduced ability of the immune system to produce antibodies, leading to recurrent infections and an increased susceptibility to autoimmune diseases and certain types of cancer. The ICOS gene plays a crucial role in the development and functioning of immune cells called T cells.
The NGS genetic test for ICOS gene immunodeficiency CVID1 involves collecting a blood or saliva sample from the patient and extracting the DNA. The DNA is then sequenced using NGS technology, which allows for the simultaneous analysis of multiple genes, including the ICOS gene. The obtained genetic data is then compared to a reference sequence to identify any mutations or variations in the ICOS gene that may be associated with CVID1.
The results of the test can help healthcare providers confirm a diagnosis of ICOS gene immunodeficiency CVID1 and provide information about the specific genetic variants involved. This information can be used to guide treatment decisions, provide genetic counseling, and offer insights into the prognosis and potential risks for family members. It is important to note that this test is a specialized diagnostic tool that is typically ordered by a healthcare professional with expertise in immunodeficiency disorders. Genetic counseling and interpretation of the test results by a qualified geneticist or immunologist are usually recommended.
Test Name | ICOS Gene Immunodeficiency common variable type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ICOS Gene Immunodeficiency common variable type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ICOS Gene Immunodeficiency common variable type 1 NGS Genetic DNA Test gene ICOS |
Test Details |
ICOS gene immunodeficiency common variable type 1 NGS genetic test is a diagnostic test that uses next-generation sequencing (NGS) technology to analyze the genetic sequence of the ICOS gene. This test is specifically designed to identify mutations or variations in the ICOS gene that are associated with common variable immunodeficiency type 1 (CVID1). CVID1 is a primary immunodeficiency disorder characterized by a reduced ability of the immune system to produce antibodies, leading to recurrent infections and an increased susceptibility to autoimmune diseases and certain types of cancer. The ICOS gene plays a crucial role in the development and functioning of immune cells called T cells. The NGS genetic test for ICOS gene immunodeficiency CVID1 involves collecting a blood or saliva sample from the patient and extracting the DNA. The DNA is then sequenced using NGS technology, which allows for the simultaneous analysis of multiple genes, including the ICOS gene. The obtained genetic data is then compared to a reference sequence to identify any mutations or variations in the ICOS gene that may be associated with CVID1. The results of the test can help healthcare providers confirm a diagnosis of ICOS gene immunodeficiency CVID1 and provide information about the specific genetic variants involved. This information can be used to guide treatment decisions, provide genetic counseling, and offer insights into the prognosis and potential risks for family members. It is important to note that this test is a specialized diagnostic tool that is typically ordered by a healthcare professional with expertise in immunodeficiency disorders. Genetic counseling and interpretation of the test results by a qualified geneticist or immunologist are usually recommended. |